Adynxx Inc (ADYX)
0.00
USD |
OTCM |
May 09, 16:00
Adynxx Cash from Financing (TTM): 3.409M for Sept. 30, 2019
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
September 30, 2019 | 3.409M |
June 30, 2019 | 2.559M |
March 31, 2019 | -14.60M |
December 31, 2018 | -12.89M |
September 30, 2018 | -12.89M |
June 30, 2018 | -14.63M |
March 31, 2018 | 3.296M |
December 31, 2017 | 3.391M |
September 30, 2017 | 3.389M |
June 30, 2017 | 3.33M |
March 31, 2017 | 0.003M |
December 31, 2016 | -4.375M |
September 30, 2016 | -4.375M |
June 30, 2016 | -2.643M |
March 31, 2016 | 43.68M |
December 31, 2015 | 46.30M |
September 30, 2015 | 46.33M |
June 30, 2015 | 46.41M |
March 31, 2015 | 20.08M |
December 31, 2014 | 20.30M |
September 30, 2014 | 33.71M |
June 30, 2014 | 33.70M |
March 31, 2014 | 16.50M |
December 31, 2013 | 16.73M |
September 30, 2013 | 4.067M |
Date | Value |
---|---|
June 30, 2013 | 4.357M |
March 31, 2013 | 1.566M |
December 31, 2012 | 2.052M |
September 30, 2012 | 1.277M |
June 30, 2012 | 0.987M |
March 31, 2012 | 0.987M |
December 31, 2011 | 0.99M |
September 30, 2011 | 0.99M |
June 30, 2011 | 0.99M |
March 31, 2011 | 2.54M |
December 31, 2010 | 1.55M |
September 30, 2010 | 1.521M |
June 30, 2010 | 1.776M |
March 31, 2010 | 0.3709M |
December 31, 2009 | 0.3709M |
September 30, 2009 | 0.4001M |
June 30, 2009 | 0.1453M |
March 31, 2009 | 4.531M |
December 31, 2008 | 4.531M |
September 30, 2008 | 4.531M |
June 30, 2008 | 4.531M |
March 31, 2008 | 2.099M |
December 31, 2007 | 2.259M |
September 30, 2007 | 2.646M |
June 30, 2007 | 3.146M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
2.559M
Minimum
Jun 2019
3.409M
Maximum
Sep 2019
2.984M
Average
2.984M
Median
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Oragenics Inc | 0.2839M |